Concepedia

Erika M. Lisabeth

EM

12

Publications

519

Citations

12

H-Index

2012

Active since

Affiliations

Michigan State University(Current)

University of Michigan

University of California San Diego

Sanford Burnham Prebys Medical Discovery Institute

Erika M. Lisabeth is an author at Michigan State University specializing in radiation oncology, medicine, and tumor biology.

ORCID

Top concepts

Publications per year

2012–2022

12

Publications

12

Cancer Somatic Mutations Disrupt Functions of the EphA3 Receptor Tyrosine Kinase through Multiple Mechanisms

Erika M. Lisabeth, C. Fernández, Elena B. Pasquale · Biochemistry · 2012 · 71 citations

, , +14

Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis

Cynthia Yu‐Wai‐Man, Bradley Spencer‐Dene, Richard M. H. Lee et al. · Scientific Reports · 2017 · 64 citations · Full text

Rho-mediated signaling promotes BRAF inhibitor resistance in de-differentiated melanoma cells

Sean A. Misek, Kate M. Appleton, Thomas S. Dexheimer et al. · Oncogene · 2019 · 58 citations · Full text

, , +7

Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma

Kim Hutchings, Erika M. Lisabeth, Walajapet G. Rajeswaran et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 56 citations · Full text

, , +6

Attenuation of Eph Receptor Kinase Activation in Cancer Cells by Coexpressed Ephrin Ligands

Giulia Falivelli, Erika M. Lisabeth, Elena Rubio de la Torre et al. · PLoS ONE · 2013 · 55 citations · Full text

Rows per page

1–5 of 12